CytoSolv, Inc.
Innovative healing technology focused on curing diabetic ulcers.
Innovative healing technology focused on curing diabetic ulcers.
CytoSolv is a biotechnology startup that focuses on developing innovative healing technology to cure diabetic ulcers. Founded in 2009 and headquartered in Tiverton, Rhode Island, the company has garnered attention for its unique approach to addressing a critical medical issue. CytoSolv Inc. received a $150.00K grant investment from the National Science Foundation on 20 December 2012, highlighting the recognition and support for its groundbreaking work in the field of biotechnology. With a strong emphasis on addressing the pressing need for effective diabetic ulcer treatments, CytoSolv Inc. presents a compelling investment opportunity in the booming biotechnology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $150.00K | 1 |
|
20 Dec 2012 |
| Seed Round | $500.00K | 1 |
|
09 Feb 2010 |
No recent news or press coverage available for CytoSolv, Inc..
We care about your data, and we'd love to use cookies make your experience better.
